Table II.
SET, PP2A and β-catenin expression and patient characteristics.
Gender | Age, years | Dukes’ stage | Differentiation degree | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||||
Expression | Male, n | Female, n | ≥50 | <50 | A | B | C | D | Well | Moderate | Poor |
Upregulation | |||||||||||
SET | 13 | 9 | 15 | 7 | 1 | 8 | 10 | 3 | 2 | 19 | 1 |
PP2A | 5 | 3 | 4 | 4 | 0 | 6 | 1 | 1 | 1 | 6 | 1 |
β-catenin | 14 | 8 | 15 | 7 | 2 | 9 | 9 | 2 | 2 | 19 | 1 |
Downrugulation | |||||||||||
SET | 5 | 4 | 6 | 3 | 1 | 6 | 2 | 0 | 2 | 6 | 1 |
PP2A | 13 | 10 | 16 | 7 | 2 | 8 | 11 | 2 | 3 | 19 | 1 |
β-catenin | 13 | 10 | 16 | 7 | 2 | 8 | 11 | 2 | 3 | 19 | 1 |
PPA2, protein phosphatase 2.